Multiple Myeloma There is hope. There is a way forward.
information · support · hope
It is always better to be an informed patient.
News, testimonies, a space to share ideas and links that help patients and carers understand the disease better and know where to find help.
Automatic translation by MielomaAI. The original text is in Portuguese. Some parts may still appear in Portuguese while they are being translated. Português
Summary · Research
Research into multiple myeloma is progressing rapidly. In particular, a bispecific antibody targeting BCMA is being tested in the US for the treatment of refractory cases. Furthermore, recent studies, such as EXCALIBER-RRMM in the US and a multi-center study in Asia, are exploring the relationship between MRD negativity and survival in patients with refractory multiple myeloma.
Made by MielomaAI On November 17, 2026, at 11:43, based on recent news. May contain errors. View news →
In the last 3 months. On the site you’ll find the news from the last 3 months. The older ones only have the title and a link, in file by topicsIt’s a support website for people with multiple myeloma. It aims to keep things simple and clear. MielomaAI As you may find.
Collected from Portuguese newspapers, Google News (PT, EN, ES, FR) and associations and scientific societies. They are on the website 197 news: only from the last 3 months. The older ones are only shown with the title and link, in file by topicsAnd research and the MielomaAI You continue to find them. Always consult the original news article and speak with your doctor before drawing conclusions about your case. Last update: November 17, 2026, 3:21 PM.
Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that two abstracts highlighting real-world clinical outcomes for Pepaxti (melflufen) in relapsed, refractory multiple myeloma (RRMM) have been accepted for presentation at the 68th American Society…
The symbol brings together two stories: that of the macedotuga.com, from Vila do Conde, and that of multiple myeloma.
The colours. The original emblem has the colours of the Portuguese flag. Here, the green and red have become two shades of blue — light blue is the colour associated with health.
The arches. At the bottom are the arches of the Santa Clara aqueduct in Vila do Conde, the town where Gualter was born and to which he returned in 2017 to face the illness close to his family. The arches of Vila do Conde stand for the bond between everyone who fights for and helps people with MM.
The connected cells. In place of the armillary sphere are three plasma cells — the bone marrow cells where multiple myeloma starts. They are linked together: patients, carers, doctors and associations. No one should walk this path alone.
MM. Multiple Myeloma.
It is always better to be an informed patient. There is hope. There is a way forward.